Stephen Z. Fadem

Last updated

Stephen Zale Fadem is an American nephrologist and medical educator specializing in kidney disease management, dialysis, and nephrology education. [1]

Contents

Early life and education

Stephen Zale Fadem was raised in Tulsa, Oklahoma, and relocated to Houston, Texas, in 1973. He is married to Joyce and has three children. He completed his high school education at Thomas Edison High School in Tulsa. He pursued undergraduate studies at Tulane University in New Orleans, Louisiana, and subsequently earned his M.D. from the University of Oklahoma College of Medicine on June 10, 1973. [2]

Career and research

Fadem completed an internship in Internal Medicine at the University of Texas Medical School at Houston Affiliated Hospitals. He continued his training with a residency in Internal Medicine at the same institution. Subsequently, he pursued a fellowship in Renal Diseases at the University of Texas Science Center in San Antonio. [3] [4]

He has made contributions to nephrology through publications covering topics such as drug abuse among teenagers, corticosteroid therapy for acute renal allograft rejection, and the impact of different treatments and conditions on renal function. [5] [6] His publications include collaborative research on renal circulation, the effects of prostaglandin E, and drug-induced vasodilation on the kidney. [7] Fadem has participated in several clinical trials. [8]

His areas of interest include the preservation of kidney function, fall prevention, vascular calcification, hereditary kidney disease, immune-mediated kidney disease, and aging. [9]

Fadem has edited Issues in Dialysis (Nova Science, Hauppauge, NY, 2012) [10] and Essentials of Chronic Kidney Disease (Nova Science, Hauppauge, NY, 2015) [11] He is Senior Editor of the four-volume series Issues in Kidney Disease (Nova Science, Hauppauge, NY, 2021). [12]

He is also the senior author of Staying Healthy with Kidney Disease (Springer-Nature, Cham, 2022); [13] and the author of Understanding and Preventing Falls (Springer-Nature, 2023). [14] In 2023, he co-edited Complications in Dialysis (Springer-Nature). [15] He is currently editing Aging in Kidney Disease, to be published by Elsevier in (forthcoming) [16]

Awards and recognition

Fadem has received awards from the National Kidney Foundation and the American Association of Kidney Patients. [17] He received the Distinguished Service Award from the National Kidney Foundation of Southeast Texas in 1999. In 2023, he was honored with the Distinguished Nephrology Service Award from the Renal Physicians Association. [18] He received the AAKP Medal of Excellence in 2019 and has twice been awarded the President’s Volunteer Service Award (2020, 2022) for his contributions to AAKP, the VA, and NKF.

Fadem is a member of the American Society of Nephrology (Fellow), the American College of Physicians (Fellow). [19] and the American Board of Quality Assurance and Utilization Review Physicians (Fellow). [20]

Selected publications

References

  1. ↑ "Houston Kidney Associates | Stephen Z. Fadem, M.D., FACP, FASN" . Retrieved 2024-05-09.
  2. ↑ "Best Nephrologists Near Me in South Houston, TX | WebMD". doctor.webmd.com. Retrieved 2024-05-09.
  3. ↑ "Stephen Z. Fadem, M.D., FASN – BIO" . Retrieved 2025-08-24.
  4. ↑ "Stephen Z. Fadem, M.D., FACP, FASN – Provider Profile" . Retrieved 2025-08-24.
  5. ↑ "archives.nida.nih.gov" (PDF). Archived from the original (PDF) on August 5, 2023.
  6. ↑ Vineyard, Gordon C.; Fadem, Stephen Z.; Dmochowski, Jan; Carpenter, Charles B.; Wilson, Richard E. (May–June 1974). "Evaluation of corticosteroid therapy for acute renal allograft rejection" . Critical Care Medicine. 2 (3): 165. doi:10.1097/00003246-197405000-00011.
  7. ↑ Lifschitz, Meyer D.; Patak, Ram V.; Fadem, Stephen Z.; Stein, Jay H. (1978-10-01). "Urinary prostaglandin E excretion: Effect of chronic alterations in sodium intake and inhibition of prostaglandin synthesis in the rabbit" . Prostaglandins. 16 (4): 607–619. doi:10.1016/0090-6980(78)90191-0. ISSN   0090-6980. PMID   725091.
  8. ↑ "PubMed search results for "S Fadem" clinical trial". PubMed. Retrieved 2025-08-24.
  9. ↑ "Stephen Z. Fadem, M.D., FASN – BIO" . Retrieved 2025-08-24.
  10. ↑ Stephen Z. Fadem, ed. (2012). Issues in Dialysis. Hauppauge, NY: Nova Science Publishers. ISBN   978-1-62100-848-4.
  11. ↑ Stephen Z. Fadem, ed. (2015). Essentials of Chronic Kidney Disease. Hauppauge, NY: Nova Science.
  12. ↑ Stephen Z. Fadem, ed. (2021). Issues in Kidney Disease. Hauppauge, NY: Nova Science. ISBN   978-1-68507-000-7.
  13. ↑ Stephen Z. Fadem, ed. (2022). Staying Healthy with Kidney Disease: A Complete Guide for Patients. Cham: Springer Nature. ISBN   978-3-030-93527-6.
  14. ↑ Stephen Z. Fadem (2023). Understanding and Preventing Falls. Springer Nature.
  15. ↑ Stephen Z. Fadem, ed. (2023). Complications in Dialysis. Springer Nature.
  16. ↑ "Stephen Z. Fadem, M.D., FASN – BIO" . Retrieved 2025-08-24.
  17. ↑ "Stephen Z. Fadem". AAKP. 2019-12-10. Retrieved 2024-05-09.
  18. ↑ "RPA Recognizes Excellence in Practice and Service - Renal Physicians Association". www.renalmd.org. Retrieved 2024-05-09.
  19. ↑ "Kidney Resource Page". nephron.org. Retrieved 2024-05-09.
  20. ↑ "Stephen Z. Fadem, M.D., FACP, FASN – Provider Profile" . Retrieved 2025-08-24.
  21. ↑ Kim, S; Fadem, S (Dec 2018). "Communication matters: Exploring older adults' current use of patient portals". International Journal of Medical Informatics. 120: 126–136. doi:10.1016/j.ijmedinf.2018.10.002. PMID   30409351.
  22. ↑ Van Buren, PN; Lewis, JB; Dwyer, JP; Greene, T; Middleton, J; Sika, M; Umanath, K; Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Fadem, SZ; Goral, S; Koury, M; Sinsakul, MV; Weiner, DE (Sep 2015). "The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial". American Journal of Kidney Diseases. 66 (3): 479–488. doi:10.1053/j.ajkd.2015.05.019. PMID   26162728.
  23. ↑ Walker, AG; Sibbel, S; Wade, C; Moulton, N; Marlowe, G; Young, A; Fadem, SZ; Brunelli, SM (Mar–Apr 2021). "SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States". Kidney Medicine. 3 (2): 216–222.e1. doi:10.1016/j.xkme.2020.12.003. PMC   7873827 . PMID   33521719.
  24. ↑ Sprague, SM; Weiner, DE; Tietjen, DP; Pergola, PE; Fishbane, S; Block, GA; Silva, AL; Fadem, SZ; Lynn, RI; Fadda, G; Pagliaro, L; Zhao, S; Edelstein, S; Spiegel, DM; Rosenbaum, DP (2024-02-07). "Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study". Kidney360.
  25. ↑ Price, RC; Tietjen, DP; Spiegel, DM; Edelstein, S; Yang, Y; Rosenbaum, DP; Fadem, SZ (May–Jun 2025). "The Positive Impact of Patient Education on Tenapanor Adherence in the OPTIMIZE Study". Nephrology Nursing Journal. 52 (3): 295–304.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.